Druggio Logo

Druggio

Kaken Pharmaceutical

Kaken Pharmaceutical is a Japanese pharmaceutical company founded in 1947. The company focuses on the research, development, and commercialization of pharmaceutical products primarily in the therapeutic areas of dermatology, pain management, and ophthalmology. Some of their key drugs include anti-infective agents, antifungals, anti-inflammatory agents, and migraine treatments. Kaken Pharmaceutical has a strong presence in the Japanese pharmaceutical market and continues to expand its reach globally.

Kaken Pharmaceutical's Drugs

Clenafin

Approval date

2014/7/4

Ecclock

Approval date

2020/9/25

Fiblast

Approval date

2001/4/4

GHRP

Approval date

2004/10/22

Hernicore

Approval date

2018/3/23